New research proves the validity of one of the most promising approaches for combating Alzheimer's disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease itself, scientists are reporting.
Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue
Amazon Music
Pages
Links
- ADHD genes and risk factors
- Alzheimer's disease genes and risk factors
- Anorexia Genes and risk factors
- Alzheimer's genes and Herpes simplex
- Autism genes and risk factors
- Bipolar disorder genes and risk factors
- Bornavirus/host interactome
- Borrelia burgdorferi interactome
- Chlamydia pneumoniae interactome
- Helicobacter Pylori host/pathogen interactome
- Herpes simplex host/pathogen interactome
- P.Gingivalis interactome
- T.Gondii: Host/pathogen interactome
- BOOKSTORE
- Childhood Obesity genes and risk factors
- Chronic Fatigue genes and risk factors
- Depression genes and risk factors
- Multiple sclerosis Genes and risk factors
- Parkinson's disease Genes and risk factors
- Pathways in disease (KEGG)
- Schizophrenia Genes and risk factors
- The Microbiome in disease
- Google Scholar
- Cpr/Aed Online Training Certification AHA&ECC Certified
- ACLS Online Certification
Blog Archive
MicrobeWorld
Microbiology Blog: The weblog for microbiologists
pubmed: microbiome disease
- The Gut-Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications
- CO-Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity
- Genome sequence of Eubacterium callanderi AM6, isolated from a Parkinson's disease patient
- The immune response modulated by inoculation of commensal bacteria at birth impacts the gut microbiota and prevents Salmonella colonization
- Tas2r105 ameliorates gut inflammation, possibly through influencing the gut microbiota and metabolites
No comments:
Post a Comment